Phillip P. Chan
Chief Executive Officer at Cytosorbents Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Cytosorbents Corporation, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cytosorbents Corporation August 13, 202691.4%
-
Cytosorbents Corporation June 12, 202595.1%
-
Cytosorbents Corporation June 6, 202492.0%
-
Cytosorbents Corporation June 6, 202396.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Cytosorbents Corporation | Open-market purchase | +3,774 | $6.00 | $22,644 |
| Sep 4, 2026 | Cytosorbents Corporation | Open-market purchase | +200,000 | $0.35 | $70,000 |
| Jun 15, 2026 | Cytosorbents Corporation | Open-market purchase | +10,333 | $0.43 | $4,443 |
| Jun 12, 2026 | Cytosorbents Corporation | Open-market purchase | +251,136 | $0.40 | $100,454 |
| Nov 18, 2025 | Cytosorbents Corporation | Grant or award | +100,000 | $0.64 | $64,000 |
| Aug 8, 2025 | Cytosorbents Corporation | Grant or award | +105,600 | — | — |
| Feb 24, 2025 | Cytosorbents Corporation | Out-of-the-money exercise | +34,168 | $1.13 | $38,610 |
| Jan 17, 2025 | Cytosorbents Corporation | In-the-money exercise | +90,832 | $1.00 | $90,832 |
| Apr 2, 2024 | Cytosorbents Corporation | Grant or award | +96,000 | — | — |
| Dec 13, 2023 | Cytosorbents Corporation | Open-market purchase | +75,188 | $1.33 | $100,000 |
| Jul 7, 2023 | Cytosorbents Corporation | Grant or award | +87,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.